• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小梁切除术失败的危险因素]

[Risk factors for trabeculectomy failure].

作者信息

Koller T L, Stürmer J, Gloor B

机构信息

Augenklinik des Universitätsspitales Zürich.

出版信息

Klin Monbl Augenheilkd. 1998 Jul;213(1):1-8. doi: 10.1055/s-2008-1034936.

DOI:10.1055/s-2008-1034936
PMID:9743932
Abstract

BACKGROUND

Trabeculectomy is today the filtering procedure of choice, because complications are rare and success-rates high. A modification of our technique (fornix-based conjunctival flap closed by a running suture) introduced 3 years ago, has lead us to this retrospective assessment of complications and success-rates. Some of the risk factors for failure are known, others however remain obscure. This retrospective series was also used to further identify some of these risk factors for trabeculectomy failure.

PATIENTS AND METHODS

All 388 trabeculectomies performed between January 1992 and June 1994 at our hospital were included in the study. Important pre- and postoperative data were retrospectively assessed from patients case notes, with a special interest in the course of post-operative intra-ocular pressure (IOP). Two major groups were differentiated: Those with open-angle glaucoma (OAG) (i.e. primary open-angle glaucoma (POAG), pseudoexfoliation glaucoma (PEX) and pigment dispersion syndrome (PDS)), and other various glaucoma diagnoses. Risk factors were assessed using Cox-proportional hazard model adopting three different criteria for success.

RESULTS

The best success-rate after 12 months of follow-up had patients with narrow angle glaucoma (93.1%)(at least those suitable for filtering surgery), followed by patients with POAG (92.8%), 2 degrees open-angle glaucoma (81.8%), aphakic (75%), juvenile (70.6%) and PDS (52.9%). Pseudophakia and development of an encapsulated bleb (Tenon' cyst) were identified as significant (p < 0.05) risk factors for failure. In addition, YAG-Laser Iridotomy in OAG-group and Aphakia in the group of various glaucoma diagnoses were identified as risk factors for successful post-operative IOP control.

CONCLUSIONS

Filtering surgery (trabeculectomy) is a potent method to reduce IOP. Pseudophakia and an encapsulated bleb are the main risk factors for surgical failure. Because of amazingly high success-rates we tend to perform filtering surgery today earlier than ten years ago, especially as previous long-term topical antiglaucoma treatment may reduce filtering surgery success.

摘要

背景

小梁切除术是目前首选的滤过手术,因为并发症少见且成功率高。3年前我们引入了一种改良技术(采用连续缝合关闭穹窿部结膜瓣),促使我们对并发症和成功率进行了此次回顾性评估。一些导致手术失败的风险因素已为人所知,但其他一些因素仍不清楚。这个回顾性系列研究还用于进一步确定小梁切除术失败的一些风险因素。

患者与方法

本研究纳入了1992年1月至1994年6月在我院进行的所有388例小梁切除术。从患者病历中回顾性评估重要的术前和术后数据,特别关注术后眼压(IOP)的变化过程。分为两大组:开角型青光眼(OAG)组(即原发性开角型青光眼(POAG)、剥脱性青光眼(PEX)和色素性青光眼综合征(PDS)),以及其他各种青光眼诊断组。采用Cox比例风险模型,根据三种不同的成功标准评估风险因素。

结果

随访12个月后,窄角型青光眼患者的成功率最高(93.1%)(至少是那些适合滤过手术的患者),其次是POAG患者(92.8%)、2级开角型青光眼患者(81.8%)、无晶状体眼患者(75%)、青少年患者(70.6%)和PDS患者(52.9%)。人工晶状体植入和包裹性滤泡(Tenon囊肿)的形成被确定为导致手术失败的显著(p<0.05)风险因素。此外,OAG组的YAG激光虹膜切开术和各种青光眼诊断组的无晶状体眼被确定为术后眼压成功控制的风险因素。

结论

滤过手术(小梁切除术)是降低眼压的有效方法。人工晶状体植入和包裹性滤泡是手术失败的主要风险因素。由于成功率惊人地高,我们现在倾向于比十年前更早地进行滤过手术,特别是因为之前长期的局部抗青光眼治疗可能会降低滤过手术的成功率。

相似文献

1
[Risk factors for trabeculectomy failure].[小梁切除术失败的危险因素]
Klin Monbl Augenheilkd. 1998 Jul;213(1):1-8. doi: 10.1055/s-2008-1034936.
2
[Encapsulated filtering blebs--incidence and methods of treatment].[包裹性滤过泡——发病率及治疗方法]
Srp Arh Celok Lek. 2001 Nov-Dec;129(11-12):296-9.
3
Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure.在人工晶状体植入的开角型青光眼患者中使用丝裂霉素C进行小梁切除术:手术效果及失败的危险因素
Am J Ophthalmol. 2006 Apr;141(4):652-9. doi: 10.1016/j.ajo.2005.11.039.
4
Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.丝裂霉素C辅助小梁切除术:有晶状体性开角型青光眼的手术效果及失败风险因素
Ophthalmology. 2006 Jun;113(6):930-6. doi: 10.1016/j.ophtha.2006.01.062. Epub 2006 Apr 27.
5
Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.先天性白内障手术后无晶状体眼和人工晶状体眼儿童青光眼采用或不采用丝裂霉素C的小梁切除术。
Eye (Lond). 2003 Jan;17(1):53-62. doi: 10.1038/sj.eye.6700180.
6
Long-term follow up of surgical repair of late bleb leaks after glaucoma filtering surgery.青光眼滤过术后晚期滤泡渗漏手术修复的长期随访
J Glaucoma. 2006 Oct;15(5):432-6. doi: 10.1097/01.ijg.0000212257.02702.e8.
7
[5-fluorouracil in the treatment of postoperative glaucoma].[5-氟尿嘧啶治疗术后青光眼]
Srp Arh Celok Lek. 1996 Jul-Aug;124(7-8):190-2.
8
Non-enhanced trabeculectomy by non-glaucoma specialists: are results related to risk factors for failure?非青光眼专科医生实施的非强化小梁切除术:结果与失败风险因素有关吗?
Eye (Lond). 2001 Feb;15(Pt 1):45-51. doi: 10.1038/eye.2001.12.
9
Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma.开角型青光眼再次小梁切除术与初次小梁切除术的长期预后
Am J Ophthalmol. 2009 Nov;148(5):685-695.e1. doi: 10.1016/j.ajo.2009.05.032.
10
[Non-penetrating deep sclerectomy combined with a collagen implant in primary open-angle glaucoma. Medium-term retrospective results].[非穿透性深层巩膜切除术联合胶原植入物治疗原发性开角型青光眼。中期回顾性结果]
J Fr Ophtalmol. 1996;19(11):659-66.

引用本文的文献

1
Outcome of combined single-loop fixation of intraocular lens with Ahmed glaucoma valve implantation.联合应用单环固定眼内人工晶状体与 Ahmed 青光眼引流阀植入术的疗效。
BMJ Case Rep. 2023 Jun 28;16(6):e254240. doi: 10.1136/bcr-2022-254240.
2
Observational Outcomes of Initial Trabeculectomy With Mitomycin C in Patients of African Descent vs Patients of European Descent: Five-Year Results.观察性研究:与欧洲裔患者相比,非洲裔患者行丝裂霉素 C 小梁切除术的五年结局。
JAMA Ophthalmol. 2018 Oct 1;136(10):1106-1113. doi: 10.1001/jamaophthalmol.2018.2897.
3
Outcomes and Complications of Scleral-Fixated Intraocular Lens Combined with Ahmed Tube Surgery.
巩膜固定人工晶状体联合艾哈迈德引流管手术的疗效与并发症
J Ophthalmol. 2018 Mar 25;2018:9824035. doi: 10.1155/2018/9824035. eCollection 2018.